Literature DB >> 10212279

Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured fisher rat thyroid cells.

M Marinò1, G Zheng, R T McCluskey.   

Abstract

We recently reported that megalin (gp330), an endocytic receptor found on the apical surface of thyroid cells, binds thyroglobulin (Tg) with high affinity in solid phase assays. Megalin-bound Tg was releasable by heparin. Here we show that Fisher rat thyroid (FRTL-5) cells, a differentiated rat thyroid cell line, can bind and endocytose Tg via megalin. We first demonstrated that FRTL-5 cells express megalin in a thyroid-stimulating hormone-dependent manner. Evidence of Tg binding to megalin on FRTL-5 cells and on an immortalized rat renal proximal tubule cell line (IRPT cells), was obtained by incubating the cells with 125I-Tg, followed by chemical cross-linking and immunoprecipitation of 125I-Tg with antibodies against megalin. To investigate cell binding further, we developed an assay in which cells were incubated with unlabeled Tg at 4 degrees C, followed by incubation with heparin, which released almost all of the cell-bound Tg into the medium. In solid phase experiments designed to illuminate the mechanism of heparin release, we demonstrated that Tg is a heparin-binding protein, as are several megalin ligands. The amount of Tg released by heparin from FRTL-5 and IRPT cells, measured by enzyme-linked immunosorbent assay (ELISA), was markedly reduced by two megalin competitors, receptor-associated protein (RAP) and 1H2 (monoclonal antibody against megalin), indicating that much of the Tg released by heparin had been bound to megalin ( approximately 60-80%). The amount inhibited by RAP was considered to represent specific binding to megalin, which was saturable and of high affinity (Kd approximately 11.2 nM). Tg endocytosis by FRTL-5 and IRPT cells was demonstrated in experiments in which cells were incubated with unlabeled Tg at 37 degrees C, followed by heparin to remove cell-bound Tg. The amount of Tg internalized (measured by ELISA in the cell lysates) was reduced by RAP and 1H2, indicating that Tg endocytosis is partially mediated by megalin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212279     DOI: 10.1074/jbc.274.18.12898

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Binding, uptake, and degradation of internalized thyroglobulin in cultured thyroid and non-thyroid cells.

Authors:  R Botta; S Lisi; A Pinchera; A R Taddei; A M Fausto; F Giorgi; M Marinò
Journal:  J Endocrinol Invest       Date:  2010-10-15       Impact factor: 4.256

2.  Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells.

Authors:  Matthew J Rowling; Carly M Kemmis; David A Taffany; JoEllen Welsh
Journal:  J Nutr       Date:  2006-11       Impact factor: 4.798

3.  Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer.

Authors:  S Lisi; F Menconi; M A Altea; L Agate; E Molinaro; M G Castagna; D Taddei; L Grasso; A Pinchera; R Elisei; M Marinò
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

4.  Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells.

Authors:  Timothy M Chlon; David A Taffany; Joellen Welsh; Matthew J Rowling
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

5.  Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release.

Authors:  Simonetta Lisi; Aldo Pinchera; Robert T McCluskey; Thomas E Willnow; Samuel Refetoff; Claudio Marcocci; Paolo Vitti; Francesca Menconi; Lucia Grasso; Fabiana Luchetti; A Bernard Collins; Michele Marino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

6.  Kidney abnormalities in low density lipoprotein receptor associated protein knockout mice.

Authors:  S Lisi; R Botta; A Pinchera; A Bernard Collins; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

7.  Impaired thyroglobulin (Tg) secretion by FRTL-5 cells transfected with soluble receptor associated protein (RAP): evidence for a role of RAP in the Tg biosynthetic pathway.

Authors:  S Lisi; L Chiovato; A Pinchera; C Marcocci; F Menconi; E Morabito; M A Altea; R T McCluskey; M Marinò
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

8.  Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway.

Authors:  S Lisi; R Botta; G Rotondo Dottore; M Leo; F Latrofa; P Vitti; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-04-19       Impact factor: 4.256

9.  Targeting of thyroglobulin to transcytosis following megalin-mediated endocytosis: evidence for a preferential pH-independent pathway.

Authors:  M Marinò; S Lisi; A Pinchera; L Chiovato; R T McCluskey
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

Review 10.  Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.

Authors:  M Marinò; L Chiovato; S Lisi; M A Altea; C Marcocci; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.